Sharon Mates - Net Worth and Insider Trading
Sharon Mates Net Worth
The estimated net worth of Sharon Mates is at least $96 Million dollars as of 2024-11-05. Sharon Mates is the Chairman and CEO of Intra-Cellular Therapies Inc and owns about 1,070,329 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $96 Million. Details can be seen in Sharon Mates's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sharon Mates has not made any transactions after 2024-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sharon Mates
Sharon Mates Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sharon Mates owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .
Click here to see the complete history of Sharon Mates’s form 4 insider trades.
Insider Ownership Summary of Sharon Mates
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2024-08-30 | director & Chairman & President & CEO |
Sharon Mates Latest Holdings Summary
Sharon Mates currently owns a total of 1 stock. Sharon Mates owns 1,070,329 shares of Intra-Cellular Therapies Inc (ITCI) as of August 30, 2024, with a value of $96 Million.
Latest Holdings of Sharon Mates
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2024-08-30 | 1,070,329 | 89.23 | 95,505,457 |
Holding Weightings of Sharon Mates
Sharon Mates Form 4 Trading Tracker
According to the SEC Form 4 filings, Sharon Mates has made a total of 24 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 24 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 70,000 shares on August 30, 2024, which brought Sharon Mates around $5 Million.
Insider Trading History of Sharon Mates
- 1
Sharon Mates Trading Performance
Sharon Mates Ownership Network
Ownership Network List of Sharon Mates
Ownership Network Relation of Sharon Mates
Sharon Mates Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Sharon Mates is the director & Chairman & President & CEO of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include EVP & Chief Commercial Officer Mark Neumann , Chief Medical Officer Suresh K. Durgam , and VP of Finance & CFO & Secretary Lawrence J. Hineline .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Sharon Mates made 8 insider transaction in Intra-Cellular Therapies Inc (ITCI) with a net sale of 696,112. Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 156,651 shares made by Mark Neumann , a net sale of 105,827 shares made by Suresh K. Durgam , and a net sale of 140,244 shares made by Michael Halstead .
In summary, during the past 3 months, insiders sold 305,712 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 305,712 shares. During the past 18 months, 1,299,251 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,299,251 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Sharon Mates Mailing Address
Above is the net worth, insider trading, and ownership report for Sharon Mates. You might contact Sharon Mates via mailing address: C/o Intra-cellular Therapies, Inc., 3960 Broadway, New York Ny 10032.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
